Detalhe da pesquisa
1.
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.
Cancer Immunol Immunother
; 62(2): 347-57, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926059
2.
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Blood Cancer Discov
; 4(2): 150-169, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468984
3.
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.
J Clin Invest
; 132(13)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775490
4.
Activation of Notch and Myc Signaling via B-cell-Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia.
Cancer Res
; 81(24): 6117-6130, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686499
5.
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
Cancer Cell
; 39(3): 380-393.e8, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689703
6.
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models.
Blood Adv
; 7(16): 4514-4517, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477552
7.
Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding.
Mol Cell Biol
; 22(13): 4544-55, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12052864
8.
The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.
Vaccine
; 27(8): 1154-65, 2009 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19146908